Edition:
United Kingdom

People: Cytokinetics Inc (CYTK.OQ)

CYTK.OQ on NASDAQ Stock Exchange Global Select Market

11.60USD
23 Jul 2019
Change (% chg)

$-0.00 (-0.00%)
Prev Close
$11.60
Open
$11.56
Day's High
$11.70
Day's Low
$11.42
Volume
158,605
Avg. Vol
172,913
52-wk High
$11.85
52-wk Low
$5.76

Parshall, B. Lynne 

Ms. B. Lynne Parshal , Esq., is Independent Director of the Company. Ms. Parshall currently serves on the Board of Directors and as the Chief Operating Officer of Ionis Pharmaceuticals, Inc. She has held various positions of increasing responsibilities at Ionis since 1991. Prior to joining Ionis, Ms. Parshall was a partner at the law firm of Cooley LLP. Ms. Parshall served as a member of the Board of Directors of Regulus Therapeutics Inc. from January 2009 to June 2015, and prior to Regulus’ conversion to a corporation, from November 2007 to January 2009. Ms. Parshall is a member of the Licensing Executives Society and a member of the American, California, and San Diego bar associations. Ms. Parshall holds a J.D. from Stanford Law School, California and B.A. from Harvard University, Massachusetts.

Basic Compensation

Total Annual Compensation, USD 45,000
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 225,854
Fiscal Year Total, USD 270,854

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Leonard Patrick Gage

291,926

Robert Blum

2,867,840

Ching Jaw

1,099,890

Fady Malik

1,219,940

David Cragg

388,209

Robert Wong

--
As Of  31 Dec 2017